We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.38%
2 Healthcare 7.46%
3 Consumer Discretionary 5.14%
4 Industrials 5.11%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFNT.WS
5426
CALL
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$44.9K ﹤0.01%
337,500
ALYA
5427
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$44.8K ﹤0.01%
+27,479
New +$50.7K
LSF icon
5428
Laird Superfood
LSF
$46M
$44.1K ﹤0.01%
55,471
-30,681
-36% -$26.2K
WEL.WS
5429
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$44.1K ﹤0.01%
52,500
VRAY
5430
CALL
DELISTED
ViewRay, Inc.
VRAY
$44K ﹤0.01%
125,000
-275,000
-69% -$285K
TLIS
5431
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$43.9K ﹤0.01%
6,098
-4,813
-44% -$34.9K
RPID icon
5432
Rapid Micro Biosystems
RPID
$83.3M
$43.8K ﹤0.01%
43,772
+8,715
+25% +$8.81K
GLMD icon
5433
Galmed Pharmaceuticals
GLMD
$4.49M
$43.4K ﹤0.01%
155
+64
+70% +$27.7K
KRNLW
5434
CALL
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$43.2K ﹤0.01%
370,500
XHG
5435
XChange TEC
XHG
$207M
$42.6K ﹤0.01%
9
-7
-44% -$63K
PLX icon
5436
Protalix BioTherapeutics
PLX
$193M
$42.5K ﹤0.01%
21,232
-65,466
-76% -$156K
IVCPW
5437
CALL
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$42K ﹤0.01%
401,121
ALLG
5438
CALL
DELISTED
Allego N.V.
ALLG
$41.7K ﹤0.01%
+143,670
New +$325K
ARBE icon
5439
Arbe Robotics
ARBE
$89.1M
$41.5K ﹤0.01%
+14,349
New +$35.7K
SES.WS
5440
CALL
DELISTED
SES AI Corp Warrants
SES.WS
$41.3K ﹤0.01%
133,333
PSQH.WS icon
5441
CALL
PSQ Holdings Warrants
PSQH.WS
$1.25M
$41.3K ﹤0.01%
53,780
-7,333
-12% -$2.5K
ZYNE
5442
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$41K ﹤0.01%
125,835
-330,514
-72% -$118K
IDN icon
5443
Intellicheck
IDN
$58M
$40.8K ﹤0.01%
16,533
-19,454
-54% -$47.1K
SYRS
5444
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$40.4K ﹤0.01%
12,825
-65,511
-84% -$211K
TFFP
5445
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$40.1K ﹤0.01%
3,410
-4,460
-57% -$64.1K
OCFT
5446
DELISTED
OneConnect Financial Technology
OCFT
$40K ﹤0.01%
12,117
-54,889
-82% -$253K
CDAQW
5447
CALL
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$39.8K ﹤0.01%
267,617
LMDX
5448
DELISTED
LumiraDx Limited Common Shares
LMDX
$39.8K ﹤0.01%
82,907
-41,112
-33% -$21.4K
AONCW
5449
CALL
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$39.6K ﹤0.01%
256,890
FZT.WS
5450
CALL
DELISTED
FAST Acquisition Corp. II Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FZT.WS
$39.3K ﹤0.01%
56,250

Similar funds

Israel Englander's Q2 2023 Portfolio in Review

As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
  • Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.